Clinical Trial Update: Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

Phase 2 trial of omacetaxine with low-dose cytarabine in older patients with acute myeloid leukemia and high-risk myelodysplastic syndrome has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• High-risk Myelodysplastic Syndrome

Drugs mentioned

• Cytarabine (Low-Dose) (cytarabine)
• Synribo (omacetaxine mepesuccinate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-05-30